{"database": "lobbying", "table": "lobbying_activities", "rows": [[2466097, "8a568a99-8364-4064-9c65-e146a273d44a", "Q2", "WAXMAN STRATEGIES", 401103693, "340B HEALTH", 2020, "second_quarter", "PHA", "Issues affecting the 340B drug pricing program; Appropriations for 340B program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-07-15T11:43:02.520000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2466097"], "units": {}, "query_ms": 54.91425492800772, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}